Nothing Found

Health Score
Health Review
Blog

facebook
twitter
pinterest
linkedin
instagram

facebook
twitter
pinterest
linkedin
instagram

By clicking any link, you are about to leave myhealthvio.com and enter the WellSync site that they operate and control. Healthvio does not assume any responsibility for the operation, content, privacy practices, or technologies used by WellSync. By navigating to this website, you agree that you interact with WellSync at your sole risk and that your relationship with WellSync will be governed by the WellSync terms and policies.

A consult is not guaranteed to result in a prescription. WellSync does not accept insurance, and the cost of the consult does not include the cost of any prescribed medication. Individuals under the age of 18 and residents of certain states are not eligible to receive a consult. Consults are only available for select conditions and the list of treated conditions is subject to change. Visit the WellSync website for more details.

*Individual results may vary

**We reserve the right, in sole and absolute discretion, to make changes at any time and from time to time as deemed necessary

References:

1. NIH reference on Tirzepatide

2. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38–48. doi:10.1001/jama.2023.24945

2. Azuri J, Hammerman A, Aboalhasan E, Sluckis B, Arbel R. Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis. Diabetes Obes Metab. 2023; 25(4): 961-964. doi:10.1111/dom.14940

Privacy Policy | Terms and conditions | CS Policy | TCPA Compliance Policy